Olmesartan pregnancy category

Olmesartan is not recommended during pregnancy, each case should be evaluated individually by healthcare professionals. Animal reproduction studies have shown an adverse effect on the fetus, but there are no adequate and well-controlled studies in humans, or animal studies have shown no adverse effect on the fetus, but there are no adequate and well-controlled studies in pregnant women.

Pregnancy     Category C         ( by FDA )

                       Category  D        (AU TGA )

There is evidence of fetal risk based on human data, but the potential benefits from the use of the medication in pregnant women may still outweigh the risks in certain situations.